The Clinical Significance of Pre-treatment Glasgow Prognostic Score (GPS) in Metastatic Colorectal Cancer (mCRC) Patients with FOLFIRI Plus Cetuximab or Bevacizumab as First-line Treatment: A Single Institutional Analysis
頁 2023;34:239-247

The Short-term Outcomes of Laparoscopic Radiofrequency Ablation Combined with Hepatic Resection versus Hepatic Resection alone for Patients with Colorectal Liver Metastases
頁 2023;34:226-238

Can Patients with Crohn’s Disease Benefit from Two-stage Operation?
頁 2023;34:217-225

The Significance of Preoperative Radiologic Lymph Node Enlargement in Early Colorectal Cancer
頁 2023;34:208-216

The Learning Curve of Two-team TaTME for Rectal Cancer: Single Center Experience
頁 2023;34:200-207

Comparison the Outcomes between Conventional Procedure for Prolapse and Hemorrhoids and Hybrid Procedure for Prolapse and Hemorrhoids for the Treatment of Mixed Hemorrhoids
頁 2023;34:191-199

Factors Associated with Incisional Hernia Recurrence after Colorectal Surgery
頁 2023;34:183-190

A Retrospective Analysis of Lymph Node Distribution in pT1 Colorectal Adenocarcinoma
頁 2023;34:175-182